BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wen YR, Lin XW, Zhou YW, Xu L, Zhang JL, Chen CY, He J. N-glycan biosignatures as a potential diagnostic biomarker for early-stage pancreatic cancer. World J Gastrointest Oncol 2024; 16(3): 659-669 [PMID: 38577461 DOI: 10.4251/wjgo.v16.i3.659]
URL: https://www.wjgnet.com/1948-9366/full/v16/i3/659.htm
Number Citing Articles
1
Sara Khorami-Sarvestani, Samir M. Hanash, Johannes F. Fahrmann, Ricardo A. León-Letelier, Hiroyuki Katayama. Glycosylation in cancer as a source of biomarkersExpert Review of Proteomics 2024; 21(9-10): 345 doi: 10.1080/14789450.2024.2409224
2
Giulia Peduzzi, Livia Archibugi, Riccardo Farinella, Ruggero Ponz de Leon Pisani, Ludmila Vodickova, Pavel Vodicka, Bledar Kraja, Juan Sainz, David Bars-Cortina, Neil Daniel, Roberto Silvestri, Pinar Uysal-Onganer, Stefano Landi, Joanna Dulińska-Litewka, Annalisa Comandatore, Daniele Campa, David J. Hughes, Cosmeri Rizzato. The exposome and pancreatic cancer, lifestyle and environmental risk factors for PDACSeminars in Cancer Biology 2025; 113: 100 doi: 10.1016/j.semcancer.2025.05.004
3
Zeyi Zheng, Ziyu Lu, Fei Yan, Yani Song, Shuai Ren. The role of novel biomarkers in the early diagnosis of pancreatic cancer: A systematic review and meta-analysisPLOS One 2025; 20(5): e0322720 doi: 10.1371/journal.pone.0322720